Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
“Bche Albumin Fusions For The Treatment Of Cocaine Abuse”
Abstract: A method of attenuating a biological effect of cocaine exposure in a primate. Such method includes administering to the primate an amount of a BChE-albumin fusion protein comprising the amino acid substitutions A227S S315G A356W and Y360G wherein the amount of the fusion protein is effective to cause attenuation of the biological effect of cocaine exposure in the primate.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
27 June 2012
Publication Number
44/2013
Publication Type
INA
Invention Field
NO SUBJECT
Status
Email
Parent Application
Applicants
TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 Basel Street P. O. Box 3190 Petach-Tikva 49131 Israel.
Inventors
1. Liora Sklair-Tavron
10 Inbar Street Zichron Yaakov Israel.
2. Moti Rosenstock
Kibbutz Maanit D. N. Menashe 37855 Israel.
3. Liron Shemesh-Darvish
A’Shkedia 13 St. Ramat-Gan 52447 Israel.
4. Hussein Hallak
11 Rashid Street Jerusalem 9500 Israel.
5. Victor Piryatinsky
Oley Hagardom 10b/13 Netanya 42398 Israel.
6. Viktor Roschke
4702 West Virginia Avenue Bethesda MD 20814 U.S.A.
7. David Lafleur
3142 Quesada St. NW Washington DC 20015 U.S.A.
Specification
PLEASE SEE THE SPECIFICATION ATTACHED